This is a non-competitive combined synopsis/solicitation for commercial amyloid radiotracers, with the government intending to award a firm-fixed-price purchase order to Progenics Pharmaceuticals Inc. as the sole source for scientific continuity. The contractor will provide 62 amyloid radiot